Company news
Omeros Corporation news in 2021
Omeros Corporation's news releases, calls and decks from 2021, newest first.
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
December 22, 2021
Omeros Announces Agreement to Sell OMIDRIA® Franchise to Rayner Surgical in a Transaction Valued in Excess of $1 Billion
December 1, 2021
Omeros Corporation Reports Third Quarter 2021 Financial Results
November 8, 2021
Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
November 4, 2021
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021
November 3, 2021
Omeros Receives Complete Response Letter from FDA for Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA
October 17, 2021
Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMA
September 30, 2021
Omeros Corporation Reports Second Quarter 2021 Financial Results
August 8, 2021
Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021
August 2, 2021
Omeros Announces Publication Detailing the Mechanism of Action of PDE7 In Nicotine Addiction
June 9, 2021
Omeros Announces Preliminary Results from Phase 1 Clinical Trial of OMS906
June 8, 2021
Omeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with Narsoplimab
May 27, 2021
Omeros Announces Extension of FDA Review Period for Narsoplimab in HSCT-TMA
May 19, 2021
Omeros Corporation Reports First Quarter 2021 Financial Results
May 9, 2021
Omeros Corporation to Announce First Quarter Financial Results on May 10, 2021
May 4, 2021
Omeros Corporation Announces Approval of ICD-10 Codes for HSCT-TMA Diagnosis and for Narsoplimab Administration
May 3, 2021
Omeros and Quantum Leap Announce First Patients Dosed with Narsoplimab in the I-SPY COVID-19 Trial
March 22, 2021
Omeros Corporation Reports Fourth Quarter and Year-End 2020 Financial Results
February 28, 2021
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on March 1, 2021
February 24, 2021
Omeros Hires Nadia Dac as Chief Commercial Officer
January 25, 2021